Insights into novel emerging epigenetic drugs in myeloid malignancies

Por Namrata S. Chandhok, Thomas Prebet
Publicado em 2019-08-01

Acute leukemia arising after radioiodine treatment for thyroid cancer

Por Gilabert, Marine, Prebet, Thomas
Publicado em 2012

Insights into novel emerging epigenetic drugs in myeloid malignancies

Por Chandhok, Namrata S., Prebet, Thomas
Publicado no Ther Adv Hematol (2019)

Treatment of Acute Promyelocytic Leukemia for Older Patients

Por Prebet, Thomas, Gore, Steven D.
Publicado em 2011

Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system

Por Prebet, Thomas, Fenaux, Pierre, Vey, Norbert
Publicado no Haematologica (2016)

Emerging treatment options for patients with high-risk myelodysplastic syndrome

Por Bewersdorf, Jan Philipp, Carraway, Hetty, Prebet, Thomas
Publicado no Ther Adv Hematol (2020)

Hypomethylating agent combination strategies in myelodysplastic syndromes: Hopes and shortcomings

Por Ball, Brian, Zeidan, Amer, Gore, Steven D., Prebet, Thomas
Publicado no Leuk Lymphoma (2016)

HYPOMETHYLATING AGENTS (HMA) TREATMENT FOR MYELODYSPLASTIC SYNDROMES: ALTERNATIVES IN THE FRONTLINE AND RELAPSE SETTINGS

Por Uy, Natalie, Singh, Abhay, Gore, Steven D., Prebet, Thomas
Publicado no Expert Opin Pharmacother (2017)

Risk stratification in myelodysplastic syndromes: is there a role for gene expression profiling?

Por Zeidan, Amer M, Prebet, Thomas, Aldin, Ehab Saad, Gore, Steven David
Publicado em 2014

Definition of Personalized Medicine and Targeted Therapies: Does Medical Familiarity Matter?

Por Fournier, Valentyn, Prebet, Thomas, Dormal, Alexandra, Brunel, Maïté, Cremer, Robin, Schiaratura, Loris
Publicado no J Pers Med (2021)

Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure

Por Prébet, Thomas, Thepot, Sylvain, Gore, Steven D., Dreyfus, François, Fenaux, Pierre, Vey, Norbert
Publicado em 2013

Planctomycetes DNA in Febrile Aplastic Patients with Leukemia, Rash, Diarrhea, and Micronodular Pneumonia

Por Drancourt, M., Prebet, T., Aghnatios, R., Edouard, S., Cayrou, C., Henry, M., Blaise, D., Raoult, D.
Publicado no J Clin Microbiol (2014)

Epigenetics in Cancer: A Hematological Perspective

Por Stahl, Maximilian, Kohrman, Nathan, Gore, Steven D., Kim, Tae Kon, Zeidan, Amer M., Prebet, Thomas
Publicado no PLoS Genet (2016)

Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity

Por Chretien, Anne-Sophie, Le Roy, Aude, Vey, Norbert, Prebet, Thomas, Blaise, Didier, Fauriat, Cyril, Olive, Daniel
Publicado em 2014

Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia

Por Patel, Kishan K., Zeidan, Amer M., Shallis, Rory M., Prebet, Thomas, Podoltsev, Nikolai, Huntington, Scott F.
Publicado no Blood Adv (2021)

An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia

Por Lopez, Sophie, Voisset, Edwige, Tisserand, Julie C., Mosca, Cyndie, Prebet, Thomas, Santamaria, David, Dubreuil, Patrice, Sepulveda, Paulo De
Publicado no Oncotarget (2016)

Reconciliation of multiple guidelines for decision support: a case study on the multidisciplinary management of breast cancer within the DESIREE project

Por Séroussi, Brigitte, Guézennec, Gilles, Lamy, Jean-Baptiste, Muro, Naiara, Larburu, Nekane, Sekar, Booma Devi, Prebet, Coralie, Bouaud, Jacques
Publicado no AMIA Annu Symp Proc (2018)

Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia

Por Prebet, Thomas, Bertoli, Sarah, Delaunay, Jacques, Pigneux, Arnaud, Delabesse, Eric, Mozziconacci, Marie Joelle, Bidet, Audrey, Recher, Christian, Vey, Norbert
Publicado em 2014

Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure

Por Prébet, Thomas, Gore, Steven D., Thépot, Sylvain, Esterni, Benjamin, Quesnel, Bruno, Rauzy, Odile Beyne, Dreyfus, François, Gardin, Claude, Fenaux, Pierre, Vey, Norbert
Publicado em 2012

Therapeutic Targeting of c-Myc in T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Por Loosveld, Marie, Castellano, Rémy, Gon, Stéphanie, Goubard, Armelle, Crouzet, Thomas, Pouyet, Laurent, Prebet, Thomas, Vey, Norbert, Nadel, Bertrand, Collette, Yves, Payet-Bornet, Dominique
Publicado em 2014